Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Can-Fite Biopharma Ltd ADR (NY: CANF ) 3.900 +0.260 (+7.14%) Official Closing Price Updated: 8:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Can-Fite Biopharma Ltd ADR < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Friday's After-Market Session June 14, 2024 Via Benzinga Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 25, 2024 Via Benzinga Can Fite Biofarma: Q4 Earnings Insights March 28, 2024 Via Benzinga Recap: Can Fite Biofarma Q3 Earnings November 30, 2023 Via Benzinga Recap: Can Fite Biofarma Q1 Earnings June 01, 2023 Via Benzinga CANF Stock Earnings: Can Fite Biofarma Beats EPS, Beats Revenue for Q4 2023 March 28, 2024 CANF stock results show that Can Fite Biofarma beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Why Is Liver Cancer Focused Can-Fite BioPharma Stock Trading Higher Today? November 21, 2023 Can-Fite BioPharma Ltd (NYSE: CANF) announced that a patient who participated in the Phase 2 Liver Cancer Study and was treated with namodenoson had a complete response and overall survival of Via Benzinga Matson To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday October 24, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 05, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 02, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 13, 2023 It's time for another dive into the biggest pre-market stock movers as we see what's moving the market on Thursday morning! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session April 11, 2023 Via Benzinga Can-Fite Revenue FY22 Revenue Declines 4.7%, Here Is What You Need To Know March 30, 2023 Can-Fite BioPharma Ltd. (AMEX:CANF) (TASE:CANF) revenues for the year ended December 31, 2022 were $810,000, a decrease of $43,000, or 4.7%, compared to revenues of $853,000 during the twelve months... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday February 14, 2023 During Tuesday, 40 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday February 10, 2023 During Friday, 48 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday January 25, 2023 On Wednesday, 22 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday January 04, 2023 On Wednesday, 35 companies reached new 52-week lows. Via Benzinga Can-Fite's Namodenoson Increases Survival For Most Severe Patients With Advanced Liver Cancer December 28, 2022 Via Benzinga Multiple Shots On Goal: Can-Fite’s Late-Stage Clinical Pipeline Hits Positive Results December 27, 2022 By Ernest Dela Aglanu, Benzinga Via News Direct Multiple Shots On Goal: Can-Fite's Late-Stage Clinical Pipeline Hits Positive Results December 13, 2022 Multiple countries are approving Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) ’s Namodenoson for compassionate use in patients with advanced liver cancer. Via Benzinga Meet This BioPharma Company With Several Exciting Drugs In Advanced Clinical Trials November 09, 2022 Sign up for this week’s All Access giveaway here! Pnina Fishman, Ph.D., CEO of Can-Fite BioPharma (NYSE: CANF), was a guest on Benzinga’s All Access on Nov 4, 2022. Via Benzinga This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers October 27, 2022 The competition between pharmaceutical company trials to help the 2% to 3% of the population suffering from chronic psoriasis is heating up. Via Benzinga Smoking Pot Makes You 55% Less Likely To Develop This Deadly Cancer August 03, 2022 Marijuana users have 55% fewer chances of developing, one of the most common malignancies worldwide - hepatocellular carcinoma (HCC), according to a study Via Benzinga Industry Analysts Seemingly Sing Praises For This Stock After Phase III Trial Results July 14, 2022 Psoriasis is a common chronic disease mediated by the immune system. It’s characterized by red, scaly patches that form on the skin. Psoriasis affects more than 3% of the U.S. adult population — over... Via Benzinga Boeing, PriceSmart And 80 Biggest Movers From Yesterday July 13, 2022 Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share. Via Benzinga Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session July 12, 2022 Gainers Via Benzinga The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death July 11, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Alibaba, Zoom Video And 76 Biggest Movers From Yesterday July 12, 2022 Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. Via Benzinga Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday July 01, 2022 Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.